# Continuous Glucose Monitoring and Diabetes

> **NCT05840250** · NA · TERMINATED · sponsor: **Hackensack Meridian Health** · enrollment: 10 (actual)

## Conditions studied

- Diabetes

## Interventions

- **OTHER:** Continuous Glucose Monitoring and Education Support

## Key facts

- **NCT ID:** NCT05840250
- **Lead sponsor:** Hackensack Meridian Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-05-15
- **Primary completion:** 2024-09-14
- **Final completion:** 2024-09-14
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** shortage in the availability on the continuous glucose monitor making it unable to reopen enrollement
- **Last updated:** 2025-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05840250

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05840250, "Continuous Glucose Monitoring and Diabetes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05840250. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
